Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yingtan Wang"'
Autor:
Ziyao Su, Haoran Zhang, Yingtan Wang, Bingxu Chen, Zhizhen Zhang, Bin Wang, Jun Liu, Yuwei Shi, Xixi Zhao
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
Bipolar disorder (BD) is a severe psychiatric disease with high rates of misdiagnosis and underdiagnosis, resulting in a significant disease burden on both individuals and society. Abnormal neural oscillations have garnered significant attention as p
Externí odkaz:
https://doaj.org/article/e9f2430fab494864ae2150a09c3a399a
Autor:
Haoran Zhang, Xinyu Liu, Ziyao Su, Yingtan Wang, Bingxu Chen, Zhizhen Zhang, Bin Wang, Jia Zhou, Ling Zhang, Xixi Zhao
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
ObjectiveThe aim of our study was to explore the relationship between changes in neural oscillatory power in the EEG, the severity of depressive-anxiety symptoms, and the risk of suicide in MDD.Methods350 MDD patients’ demographic and clinical data
Externí odkaz:
https://doaj.org/article/2cd9c95e546e42a2a65f5b7444ba3883
Autor:
Yingtan Wang, Yu Chen, Yi Cui, Tong Zhao, Bin Wang, Yunxi Zheng, Yanping Ren, Sha Sha, Yuxiang Yan, Xixi Zhao, Ling Zhang, Gang Wang
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
BackgroundMajor depressive disorder (MDD) is the leading cause of disability among all mental illnesses with increasing prevalence. The diagnosis of MDD is susceptible to interference by several factors, which has led to a trend of exploring objectiv
Externí odkaz:
https://doaj.org/article/eb2e4f8194554e64a3efb1acf4833b14
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract At present, no well-established biomarkers were ever found to distinguish unipolar depression and bipolar disorder (BD). This study aimed to provide a clearer comparison of UA levels between BD and major depressive disorder. Peripheral UA of
Externí odkaz:
https://doaj.org/article/edbbab4a4ce8475b8be67cadc8793b56
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Recent studies show that oxidative stress is associated with the pathogenesis of schizophrenia. There are two major types of antioxidant systems in vivo, namely enzymatic antioxidants and non-enzymatic antioxidants. This study inv
Externí odkaz:
https://doaj.org/article/402fb184253a4185ace1e6ab95ac8a52
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Much evidence shows that some Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5)-defined unipolar depression (UD) with bipolarity manifests bipolar diathesis. Little is known about the cognitive profiles of patients with dep
Externí odkaz:
https://doaj.org/article/1b7b8e9e3cd44a638da8e84f58fb3cfd
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
At present, no well-established biomarkers were ever found to distinguish unipolar depression and bipolar disorder (BD). This study aimed to provide a clearer comparison of UA levels between BD and major depressive disorder. Peripheral UA of 119 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a6303e82acd6bd1eed88f3d8cd1c76f
https://doi.org/10.1038/s41598-021-97955-4
https://doi.org/10.1038/s41598-021-97955-4
Background: At present, no well-established biomarkers were ever found to distinguish unipolar depression (UD) and bipolar disorder (BD). This study aimed to provide a clearer comparison of UA levels between BD and major depressive disorder. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ef4ee18815a1330978ef141f76ccc13
https://doi.org/10.21203/rs.3.rs-137483/v2
https://doi.org/10.21203/rs.3.rs-137483/v2
Background: At present, no well-established biomarkers were ever found to distinguish unipolar disorder (UD) and bipolar disorder (BD). This study aimed to explore whether uric acid (UA) could be a biomarker to distinguish UD and BD. Methods: Periphe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bbd9bcf8a05cf30fa47ff04e64dde56
https://doi.org/10.21203/rs.3.rs-137483/v1
https://doi.org/10.21203/rs.3.rs-137483/v1
Publikováno v:
Medicine
Rationale: Piribedil is an orally active dopamine agonist that has been widely used for Parkinson disease (PD), with its partial D2/D3 agonistic functions and alpha2-adrenoreceptor antagonistic effects, piribedil has been proved to be efficacious in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35cc7eef3bda751953950692f4d4465
https://pubmed.ncbi.nlm.nih.gov/33578553
https://pubmed.ncbi.nlm.nih.gov/33578553